相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
Christian D. Fankhauser et al.
BRITISH JOURNAL OF CANCER (2022)
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Isamu Tachibana et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy
Antoin Douglawi et al.
JOURNAL OF UROLOGY (2020)
National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy
Craig V. Labbate et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Management of Metastatic Pure Teratoma in Chemotherapy Naive Patients With Testicular Primaries
Clint Cary et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance
Robert J. Hamilton et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Reply to J. Beyer, T. Tandstad et al, S. Gillessen et al, J. Oldenburg et al, and LC Pagliaro et al
David J. Vaughn
JOURNAL OF CLINICAL ONCOLOGY (2015)
Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors
Madhur Nayan et al.
JOURNAL OF UROLOGY (2015)
Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection
Nick W. Liu et al.
UROLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Primary Retroperitoneal Lymph Node Dissection in Low-stage Testicular Germ Cell Tumors: A Detailed Pathologic Study With Clinical Outcome Analysis With Special Emphasis on Patients Who Did Not Receive Adjuvant Therapy
Hikmat A. Al-Ahmadie et al.
UROLOGY (2013)
Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy
Stephen B. Williams et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Retroperitoneal lymph node dissection: reassessment of modified templates
Michael C. Large et al.
BJU INTERNATIONAL (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Retroperitoneal Lymph Node Dissection in Patients With High Risk Testicular Cancer
Stephen B. Williams et al.
JOURNAL OF UROLOGY (2009)
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2007)
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome
AJ Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis
KS Pohar et al.
JOURNAL OF UROLOGY (2003)
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse
F Rabbani et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment
L Weissbach et al.
EUROPEAN UROLOGY (2000)
分享论文
